← Feed

KOCH KEVIN

SEC Form 4 insider
President and CEO · Edgewise Therapeutics, Inc. ($EWTX)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$EWTXSEC Form 4bearish
KOCH KEVIN · President and CEO at Edgewise Therapeutics, Inc. · 3h agono track record yet
Sold 17,971 @ $43.68 avg · $785,042 · 2026-08-12

Form 4: KOCH KEVIN sold EWTX

KOCH KEVIN (President and CEO at Edgewise Therapeutics, Inc.) reported an open-market sale of 17,971 shares of EWTX at an average $43.68, roughly $785,042, in a Form 4 filed 2026-08-14.

View filing on SEC.gov →

End of results.